Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rabbit Anti-Equine IgG (H+L) Polyclonal Antibody

Cat. No.VD7N409

Product TypeAnimal-targeted Antibodies

Size 1mg

Product Overview

BioVenic rabbit polyclonal antibody is specific for equine IgG (H+L). It can be applied to ICC, IHC and WB assays of equine IgG (H+L).

Specifications

Application ICC; IHC; WB
Clonality Polyclonal
Classification Secondary Antibody
Clone L13N82
Host Rabbit
Target Species Equine
Species Reactivity Equine
Specificity Equine IgG
Purity > 90%
Conjugation Unconjugated
Preservative and Stabilizer Sodium Azide
Buffer 0.01M Phosphate Buffered Saline, pH 7.2
Physical State Liquid

Target Information

Equine IgG (H+L) refers to the immunoglobulin G found in horses, which is composed of two heavy chains and two light chains. Horses have a unique immunoglobulin profile, with seven IgG subclasses identified, denoted as IgG1 to IgG7. These subclasses vary in their effector functions, which has implications for vaccine strategies and therapeutic applications. The equine IgG subclasses exhibit different capabilities in terms of eliciting immune responses. For instance, IgG1, IgG3, IgG4, IgG5, and IgG7 can interact with Fc receptors on effector cells and activate the complement system via the classical pathway, suggesting their importance in immune defense.

Target Equine IgG (H+L)

Shipping and Storage

This product is shipped with wet ice packs. Store at -20°C on receipt (up to 12 months). Avoid exposure to light. Avoid repeated freezing and thawing as this may denature the antibody.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Lewis, Melanie J., et al. "The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategies." Molecular immunology 45.3 (2008): 818-827.
Inquiry Basket